HIGH-RISK NEUROBLASTOMA
Clinical trials for HIGH-RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH-RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo therapy targets tough childhood cancer
Disease control Not yet recruitingThis study tests whether adding the drug naxitamab to standard chemotherapy is safe and effective for children and young adults with high-risk neuroblastoma, an aggressive nerve cancer. Ten newly diagnosed patients will receive the combination and be monitored for side effects an…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Shaare Zedek Medical Center • Aim: Disease control
Last updated May 26, 2026 05:26 UTC
-
New scan could improve detection of childhood nerve cancer
Diagnosis Not yet recruitingThis study tests whether a new type of PET scan (18F-MFBG) can find neuroblastoma tumors as well as or better than the current standard scan (123I-MIBG). About 84 children and adults with newly diagnosed, high-risk neuroblastoma will receive both scans at different times. The goa…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Diagnosis
Last updated May 26, 2026 05:30 UTC